FdaApplication
NDA 020033
Identifiers
- fda_app_no: NDA020033
Properties
| Property | Value |
|---|---|
| applicant_name | VALIDUS PHARMACEUTICALS LLC |
| application_type | NDA |
| approval_date | 1992-05-19 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LOTENSIN HCT | BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE | 20MG;25MG | TABLET;ORAL |
| LOTENSIN HCT | BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE | 5MG;6.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| LOTENSIN HCT | BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE | 20MG;12.5MG | TABLET;ORAL |
| LOTENSIN HCT | BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE | 10MG;12.5MG | TABLET;ORAL |
4 products